advertisement
11.4 Prostaglandins (59)
Showing records 1 to 25
Display all abstracts in classification 11.4 Prostaglandins
Search within classification 11.4 Prostaglandins80061 Effect of vitamin-E integration on delivery of prostaglandin analogs from therapeutic lenses
Sekar P
Journal of Colloid and Interface Science 2019; 539: 457-467
79324 Hypotensive efficacy of bimatoprost in monotherapy of primary open-angle glaucoma
Petrov SY
Vestnik Oftalmologii 2018; 134: 208-214
79383 Thermosensitive chitosan-gelatin-based hydrogel containing curcumin-loaded nanoparticles and latanoprost as a dual-drug delivery system for glaucoma treatment
Cheng YH
Experimental Eye Research 2019; 179: 179-187
79393 Omidenepag Isopropyl Ophthalmic Solution 0.002%: First Global Approval
Duggan S
Drugs 2018; 78: 1925-1929
80056 Latanoprostene bunod ophthalmic solution 0.024%: a new treatment option for open-angle glaucoma and ocular hypertension
Fingeret M
Clinical and Experimental Optometry 2019; 102: 541-550
79334 Micropulse laser trabeculoplasty on pseuodexfoliation glaucoma patients under topical prostaglandin analogue monotherapy: 1-year results
Makri OE
Graefe's Archive for Clinical and Experimental Ophthalmology 2019; 257: 349-355
79324 Hypotensive efficacy of bimatoprost in monotherapy of primary open-angle glaucoma
Petrov SY
Vestnik Oftalmologii 2018; 134: 208-214
79679 Therapeutic efficacy of latanoprost on primary open angle glaucoma: A protocol for a systematic review of randomized controlled trial
Dai HY
Medicine 2018; 97: e13833
79765 Better tolerance of preservative-free latanoprost compared to preserved glaucoma eye drops: the 12-month real-life FREE study
Economou MA
Clinical Ophthalmology 2018; 12: 2399-2407
79324 Hypotensive efficacy of bimatoprost in monotherapy of primary open-angle glaucoma
Petrov SY
Vestnik Oftalmologii 2018; 134: 208-214
79977 Effect of a Topical Combination of Latanoprost and Pranoprofen on Intraocular Pressure and the Ocular Surface in Open-Angle Glaucoma Patients
Zhu S
Journal of Ophthalmology 2018; 2018: 7474086
79570 Latanoprostene bunod ophthalmic solution 0.024% in the treatment of open-angle glaucoma: design, development, and place in therapy
Addis VM
Clinical Ophthalmology 2018; 12: 2649-2657
79324 Hypotensive efficacy of bimatoprost in monotherapy of primary open-angle glaucoma
Petrov SY
Vestnik Oftalmologii 2018; 134: 208-214
79566 Effectiveness of 0.1% topical salicylic acid on blepharoconjunctivitis affecting glaucoma patients treated with topical prostaglandin analogues: a prospective randomized trial
Librando A
International Journal of Ophthalmology 2018; 11: 1936-1940
79846 Latanoprost could exacerbate the progression of presbyopia
Ayaki M
PLoS ONE 2019; 14: e0211631
79689 Latanoprost with high precision, piezo-print microdose delivery for IOP lowering: clinical results of the PG21 study of 0.4 µg daily microdose
Pasquale LR
Clinical Ophthalmology 2018; 12: 2451-2457
79334 Micropulse laser trabeculoplasty on pseuodexfoliation glaucoma patients under topical prostaglandin analogue monotherapy: 1-year results
Pallikari A
Graefe's Archive for Clinical and Experimental Ophthalmology 2019; 257: 349-355
79324 Hypotensive efficacy of bimatoprost in monotherapy of primary open-angle glaucoma
Kozlova IV
Vestnik Oftalmologii 2018; 134: 208-214
79765 Better tolerance of preservative-free latanoprost compared to preserved glaucoma eye drops: the 12-month real-life FREE study
Laukeland HK
Clinical Ophthalmology 2018; 12: 2399-2407
79977 Effect of a Topical Combination of Latanoprost and Pranoprofen on Intraocular Pressure and the Ocular Surface in Open-Angle Glaucoma Patients
Wang D
Journal of Ophthalmology 2018; 2018: 7474086
80061 Effect of vitamin-E integration on delivery of prostaglandin analogs from therapeutic lenses
Chauhan A
Journal of Colloid and Interface Science 2019; 539: 457-467
79383 Thermosensitive chitosan-gelatin-based hydrogel containing curcumin-loaded nanoparticles and latanoprost as a dual-drug delivery system for glaucoma treatment
Ko YC
Experimental Eye Research 2019; 179: 179-187
79846 Latanoprost could exacerbate the progression of presbyopia
Tsuneyoshi Y
PLoS ONE 2019; 14: e0211631
79689 Latanoprost with high precision, piezo-print microdose delivery for IOP lowering: clinical results of the PG21 study of 0.4 µg daily microdose
Lin S
Clinical Ophthalmology 2018; 12: 2451-2457
79679 Therapeutic efficacy of latanoprost on primary open angle glaucoma: A protocol for a systematic review of randomized controlled trial
Wang JY
Medicine 2018; 97: e13833
